Pfizer’s Prevnar posts $1.53B in Q4 sales, handily beating consensus

Pfizer's Prevnar turned in consensus-beating sales of $1.53 billion—up 7% over the same period last year—thanks to government purchases internationally and in the U.S.Original Article